Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-
From its Therapeutic Dermatology portfolio, Galderma will present data on the efficacy and safety of Nemluvio (nemolizumab) in different patient populations with moderate-to-severe atopic dermatitis, including late-breaking data in pediatri
AI is increasing cloud dependency, yet investment levels are not alignedAs legacy applications and data hold back innovation, modernization emerges as a top cloud priorityTechnology ecosystem complexity puts a spotlight on security investme
COURBEVOIE, France--(BUSINESS WIRE)--Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), is pleased to announce the expansion of its geographical scope as an Approved Verifier under the Climate Bonds
Toyoda Gosei行人保护产 
dSPACE at CES 2024: Ne 
国际机场协会(ACI World 
海博艾斯旗下Normatec亮 
